Spark Therapeutics
AcquiredGenentech
Philadelphia, United States · Founded 2013 · $72.8M raised
- Headquarters
- Philadelphia, Pennsylvania
- Employees
- 201–500
- Founded
- 2013
- Business Model
- B2B
- Website
- sparktx.com
- Total Funding
- $72.8M
- Last Round
- $72.8M Series BMay 2014
- Rounds
- 1
About
Spark Therapeutics develops gene therapy treatments for debilitating genetic diseases; acquired by Roche in 2019 and now a Roche subsidiary.
Summary
Spark Therapeutics is a Biotech company based in Philadelphia, United States, founded in 2013. It has raised $72.8M in total across 1 round, most recently a $72.8M Series B round in May 2014.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2014
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...